Search datasets
-
ZORYVE is a prescription topical foam containing roflumilast (0.3%), a phosphodiesterase 4 inhibitor used to treat plaque psoriasis in adults. It reduces inflammation in the skin. Manufactured by...
Search relevance: 170.90 | Views last month: 0 | Catalog Last Checked: September 10, 2026 at 08:16 PM -
Patent AT-E399543-T1: [Translated] NEW SYNERGISTIC COMPOSITION CONTAINING ROFLUMILAST AND FORMOTEROL
The invention relates to the combined administration of roflumilast and formoterol for the treatment of respiratory tract disorders.
Search relevance: 113.51 | Views last month: 0 | Catalog Last Checked: September 10, 2026 at 07:55 PM -
The invention relates to the combined administration of roflumilast and R,R-formoterol for the treatment of respiratory tract disorders.
Search relevance: 111.57 | Views last month: 0 | Catalog Last Checked: September 10, 2026 at 08:13 PM -
The 97th American Thoracic Society meeting proved to be an excellent meeting, providing a wealth of new information on inflammatory diseases of the airways. Once again there appeared to be an...
Search relevance: 24.95 | Views last month: 0 | Catalog Last Checked: September 10, 2026 at 08:04 PM
